Synspira

About:

Synspira Therapeutics is focused on developing a rationally designed portfolio of products in cystic fibrosis and other rare diseases.

Website: http://www.synspira.com/

Twitter/X: synspirapd

Top Investors: Cystic Fibrosis Foundation, Miller Family Trust

Description:

Synspira Therapeutics is focused on developing a rationally designed portfolio of products in cystic fibrosis and other rare diseases. Inspired by patients and frustrated by the limitations of conventional treatments, Synspira is advancing two novel products (SNSP113 and SNSP003) in order to provide better clinical outcomes and reduce treatment burden in Progressive Pulmonary Disease and Malabsorption Syndromes.